MethaCholine Bronchoprovocation Study (MeCIS)
Public ClinicalTrials.gov record NCT00705341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MethaCholine Bronchoprovocation - Influence of High Potency Inhaled corticoSteroids in Asthma (MeCIS) Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research is to evaluate the methacholine challenge test as an accurate indicator of asthma in patients receiving treatment for asthma. Phase 1 on the study compares methacholine challenge test results from asthma patients to those from people who do not have asthma. In phase 2, test results for people with asthma on low dose inhaled corticosteroid will be compared to results on high dose inhaled corticosteroids. Both males and females with stable asthma (asthma participants) and without asthma (controls) enrolled. Participants will be between 12 and 69 years of age.
Study identification
- NCT ID
- NCT00705341
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 219 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Jan 31, 2010
- Completion
- Jan 31, 2010
- Last update posted
- Feb 11, 2013
2009 – 2010
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California at San Diego | San Diego | California | 92103 | — |
| The Nemours Children's Clinic | Jacksonville | Florida | 32207 | — |
| University of Miami/Univestiy of South Florida | Miami | Florida | 33136 | — |
| Northwestern University Memorial Hospital | Chicago | Illinois | 60611 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Louisianna State University | New Orleans | Louisiana | 70112 | — |
| University of Missouri-Kansas City | Kansas City | Missouri | 64108 | — |
| Washington University School of Medicine | St Louis | Missouri | 631110 | — |
| Long Island Jewish Medical Center | New Hyde Park | New York | 11040 | — |
| New York Consortium/Columbia University | New York | New York | 10016 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Vermont Lung Center at the University of Vermont | Burlington | Vermont | 05405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Asthma trials
Other public records listing Asthma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792395: Ginger's Therapeutic Potential in Asthma Not yet recruiting
- NCT07792330: Asthma Lung Sounds With Wearable Stethoscope Not yet recruiting
- NCT07671001: A Study of Depemokimab in Participants of 6 to 11 Years of Age Recruiting
- NCT07772921: A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma Not yet recruiting
- NCT07444567: Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Recruiting
- NCT01449409: Reduce IDentified UNcontrolled Asthma Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00705341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2013 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00705341 live on ClinicalTrials.gov.